« Return to News | Awards & Advancement

Averion Names Executive Vice President of Global Biz Dev

Wednesday, August 20, 2008 09:00 AM

Averion International, an international contract research organization (CRO) specializing in oncology and cardiovascular diseases, appointed Peter Gonze executive vice president of global business development, a role that will focus on increasing Averion’s business efforts in international markets.

“We will continue to pursue new business opportunities in North America and Europe, and plan to expand our geographic and therapeutic capabilities in emerging regions of the world,” chief executive officer Markus H. Weissbach, M.D., said in a company release.

Gonze brings more than 35 years of pharma-related experience to Averion. He’s held senior-level positions at GlaxoSmithKline, RhonePoulenc Rorer (now SanofiAventis), Johnson & Johnson, Abbott Diagnostics-Medisense and AltaRed, and, most recently, he was chief operating officer of Unither Pharmaceuticals, a company focused on immunotherapeutic vaccines for oncology.

Averion isn’t the only company in the clinical trials industry creating positions to advance their global aspirations. Earlier this month, SpineMark Corporation, the parent company of SpineMark CRO, named Dr. Rudolf Bertagnoli chairman of its International Medical Advisory Board in an effort to strengthen its international presence.

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

December 17

Medici Global says its Alzheimer's Facebook page demonstrates the need for more early detection trials

Analysts: Expect more equity purchases of CROs in 2013

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

January 2013

Parexel celebrates 30 years of change, growth
CRO's founder and chairman reflects on challenges of the past, present and future

Strategies for increasing patient diversity in trials
Sponsors look to improve racial, ethnic recruitment without going overseas

Already a subscriber?
Log in to your digital subscription.

Purchase the January issue.

Subscribe to The CenterWatch Monthly.

December 2012

Publicity, regulation tightening reins on use of KOLs
Debate rages over need to revamp how sponsors use, pay medical experts

Time may be right to makeover the investigator brochure
Size, complexity prevent critical document from being thoroughly read

Already a subscriber?
Log in to your digital subscription.

Purchase the December issue.

Subscribe to The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs

More Jobs

 

Copyright © 1995-2013 CenterWatch.